| Maria Elaine Barnes, | |
|
1 Medical Village Dr, Edgewood, KY 41017-3403 | |
| (859) 301-2465 | |
| (859) 301-4941 |
| Full Name | Maria Elaine Barnes |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1 Medical Village Dr, Edgewood, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427636232 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Secondary |
| 363A00000X | Physician Assistant | PA2763 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria Elaine Barnes, Po Box 636324, Cincinnati, OH 45263-6324 Ph: (859) 344-5555 | Maria Elaine Barnes, 1 Medical Village Dr, Edgewood, KY 41017-3403 Ph: (859) 301-2465 |
News Archive
Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.
A new phase III trial with positive results is taking intravaginal DHEA a step closer to governmental approval. The formulation could provide women who cannot or do not wish to use intravaginal estrogen with an effective vaginal alternative for easing vaginal symptoms and pain with sex after menopause.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that it has initiated a next generation anthrax vaccine development program pursuant to a field-exclusive option agreement with Harvard University to negotiate a license under patent rights that cover prophylactic uses of a modified anthrax toxin protein.
President Barack Obama hailed the latest tally of people who gained insurance as a result of the health law. News outlets also look inside this latest round of data to find out what information the administration is providing and what is still to come.
› Verified 4 days ago
Mrs. Courtney E Coffey, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-9010 Fax: 859-301-9018 | |
Mr. Spencer Herbert Cole, MPAS, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 560 S Loop Rd, Edgewood, KY 41017 Phone: 859-301-2663 Fax: 659-301-0655 | |
Deborah Joy Barnett, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 20 Medical Village Dr, Edgewood, KY 41017 Phone: 859-578-5880 Fax: 859-578-5881 | |
Miss Casey Lynn Doty, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 20 Medical Village Dr # 254, Edgewood, KY 41017 Phone: 859-344-1600 Fax: 859-344-0091 | |
Catherine Kremer, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 560 S Loop Rd, Edgewood, KY 41017 Phone: 859-301-2663 Fax: 859-817-7848 | |
Mr. Matthew Giese, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 560 S Loop Rd, Edgewood, KY 41017 Phone: 859-301-2663 Fax: 859-301-0655 | |
Emily Julia Williams, Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Medical Village Drive, Edgewood, KY 41017 Phone: 859-301-2465 Fax: 859-301-4941 |